SMTL ID : 5dgm.1

Crystal structure of human FPPS in complex with monophosphonate compound 7

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

homo-dimer

Ligands

2 x 59Z: {2-[(phosphonomethyl)carbamoyl]-1H-benzo[g]indol-1-yl}acetic acid(Non-covalent)

59Z.1: 12 residues within 4Å: Chain A: Y.7, K.54, N.56, R.57, T.60, S.202, F.203, F.236, L.341, K.344, I.345 Ligands: PO4.2 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:Y.7, A:N.56, A:R.57, A:F.203, A:F.203, A:F.236, A:L.341, A:K.344, A:I.345 Hydrogen bonds: A:N.56, A:K.344 Salt bridges: A:K.54, A:R.57 59Z.3: 12 residues within 4Å: Chain B: Y.7, K.54, N.56, R.57, T.60, S.202, F.203, F.236, L.341, K.344, I.345 Ligands: PO4.4 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:Y.7, B:N.56, B:R.57, B:F.203, B:F.203, B:F.236, B:L.341, B:K.344, B:I.345 Hydrogen bonds: B:N.56, B:K.344 Salt bridges: B:K.54, B:R.57

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 6 residues within 4Å: Chain A: G.53, K.54, Y.55, Q.93, R.110 Ligands: 59Z.1 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:K.54, A:Y.55, A:R.57, A:Q.93 Water bridges: A:G.53, A:N.56, A:E.90, A:R.110 Salt bridges: A:R.110 PO4.4: 6 residues within 4Å: Chain B: G.53, K.54, Y.55, Q.93, R.110 Ligands: 59Z.3 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:K.54, B:Y.55, B:R.57, B:Q.93 Water bridges: B:N.56, B:E.90, B:E.90, B:R.110 Salt bridges: B:R.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jahnke, W. et al., A General Strategy for Targeting Drugs to Bone. Angew.Chem.Int.Ed.Engl. (2015)

Release Date

2016-07-13

Peptides

Farnesyl pyrophosphate synthase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
F

B
F

Farnesyl pyrophosphate synthase

Related Entries With Identical Sequence